Literature DB >> 3094407

Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery.

M E Ausems, C C Hug, D R Stanski, A G Burm.   

Abstract

To design an efficient infusion regimen from pharmacokinetic data, it is necessary to know the alfentanil plasma concentrations required for satisfactory anesthesia. In 37 patients about to undergo lower abdominal gynecologic, upper abdominal, or breast surgery, anesthesia was induced with alfentanil 150 micrograms/kg iv and 66% N2O in oxygen. Thereafter, N2O anesthesia was supplemented with a continuous infusion of alfentanil that was varied between 25 and 150 micrograms X kg-1 X h-1, as indicated by the patient's responses to surgical stimulation. Small bolus doses of alfentanil 7 or 14 micrograms/kg were administered and the infusion rate increased to suppress precisely defined somatic, autonomic, and hemodynamic responses. Arterial plasma concentrations of alfentanil were measured during the operation when the patient did and did not respond to noxious stimulation. Logistic regression was used to determine plasma concentration-effect curves for different stimuli. Plasma alfentanil concentrations required along with 66% N2O to obtain responses to single episodes of stimulation in 50% of the 37 patients (Cp50 +/- SE) were: 475 +/- 28 ng/ml for tracheal intubation, 279 +/- 20 ng/ml for skin incision, and 150 +/- 23 ng/ml for skin closure. Between skin incision and closure, multiple determinations of response/no response were made for each patient and an individual Cp50 was estimated. The Cp50 (mean +/- SD) for the three surgical procedures were: breast, 270 +/- 63 ng/ml (n = 12); lower abdominal, 309 +/- 44 ng/ml (n = 14); and upper abdominal, 412 +/- 135 ng/ml (n = 11). The Cp50 for satisfactory spontaneous ventilation after the discontinuation of N2O was 223 +/- 13 ng/ml. These data demonstrate that different perioperative stimuli require different alfentanil concentrations to suppress undesirable responses. Thus, the alfentanil infusion rate should be varied according to the patient's responsiveness to stimulation in order to maintain satisfactory anesthetic and operative conditions and to provide rapid recovery of consciousness and spontaneous ventilation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094407     DOI: 10.1097/00000542-198610000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  32 in total

1.  A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron.

Authors:  E H Cox; C Veyrat-Follet; S L Beal; E Fuseau; S Kenkare; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

Review 2.  Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials?

Authors:  A Grahnén; M O Karlsson
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  Pharmacokinetics and pharmacodynamics for the clinician.

Authors:  D R Stanski
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 4.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

5.  Application of semilinear canonical correlation to the measurement of opioid drug effect.

Authors:  K M Gregg; J R Varvel; S L Shafer
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

6.  Awareness during anaesthesia: when is an anaesthetic not an anaesthetic?

Authors:  A R Aitkenhead
Journal:  Can J Anaesth       Date:  1996-03       Impact factor: 5.063

7.  Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy.

Authors:  R Tempelhoff; P A Modica; E L Spitznagel
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

8.  Carbamazepine and its metabolites in neuralgias: concentration-effect relations.

Authors:  R S Moosa; M L McFadyen; R Miller; J Rubin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

10.  EEG Predicts movement response to surgical stimuli during general anesthesia with combinations of isoflurane, 70% N2O, and fentanyl.

Authors:  R C Dutton; W D Smith; N T Smith
Journal:  J Clin Monit       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.